KBC Group NV raised its position in shares of CorVel Corp. (NASDAQ:CRVL – Free Report) by 35.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,564 shares of the business services provider’s stock after purchasing an additional 406 shares during the quarter. KBC Group NV’s holdings in CorVel were worth $175,000 as of its most recent SEC filing.
A number of other large investors have also made changes to their positions in CRVL. Kayne Anderson Rudnick Investment Management LLC grew its stake in shares of CorVel by 193.7% during the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,714,351 shares of the business services provider’s stock valued at $635,779,000 after purchasing an additional 3,768,440 shares during the period. Vanguard Group Inc. lifted its position in shares of CorVel by 202.1% during the 4th quarter. Vanguard Group Inc. now owns 3,281,649 shares of the business services provider’s stock valued at $365,116,000 after buying an additional 2,195,466 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of CorVel by 184.1% during the 4th quarter. Renaissance Technologies LLC now owns 1,858,830 shares of the business services provider’s stock valued at $206,813,000 after buying an additional 1,204,611 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of CorVel by 187.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,545,619 shares of the business services provider’s stock valued at $171,969,000 after buying an additional 1,007,651 shares in the last quarter. Finally, Neuberger Berman Group LLC lifted its position in shares of CorVel by 204.6% during the 4th quarter. Neuberger Berman Group LLC now owns 845,531 shares of the business services provider’s stock valued at $94,074,000 after buying an additional 567,984 shares in the last quarter. 51.36% of the stock is currently owned by institutional investors.
CorVel Stock Up 1.4%
CRVL stock opened at $102.83 on Monday. CorVel Corp. has a twelve month low of $83.37 and a twelve month high of $128.61. The stock has a market cap of $5.29 billion, a P/E ratio of 55.98 and a beta of 0.98. The business’s 50-day moving average price is $108.44 and its 200-day moving average price is $114.10.
Insider Buying and Selling
In related news, Director Alan Hoops sold 3,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $113.05, for a total value of $339,150.00. Following the transaction, the director directly owned 16,688 shares of the company’s stock, valued at approximately $1,886,578.40. The trade was a 15.24% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Jennifer Yoss sold 1,050 shares of the business’s stock in a transaction that occurred on Thursday, May 29th. The stock was sold at an average price of $111.39, for a total value of $116,959.50. Following the completion of the transaction, the vice president directly owned 2,088 shares in the company, valued at approximately $232,582.32. This represents a 33.46% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 29,602 shares of company stock worth $3,379,049 in the last quarter. 44.56% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen raised CorVel from a “hold” rating to a “buy” rating in a research report on Friday, April 18th.
Get Our Latest Analysis on CRVL
CorVel Profile
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Featured Stories
- Five stocks we like better than CorVel
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Forget the Weak Dollar—These 3 Travel Stocks Are Still Taking Off
- Stock Splits, Do They Really Impact Investors?
- Correction Equals Opportunity in Domino’s Pizza Stock
- Stock Analyst Ratings and Canadian Analyst Ratings
- 3 Defense Leaders Set to Gain From Rising Military Spend
Want to see what other hedge funds are holding CRVL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CorVel Corp. (NASDAQ:CRVL – Free Report).
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.